Already Registered? Log In Now
Not Registered?
Business Email:
Complete this form to enter the webcast.
Already Registered?
(* indicates required field)
Complete this form to enter the webcast.
(* indicates required field)
Business Email*:
First Name*:
Last Name*:
Title*:
Company Name*:
Street Address 1*:
Street Address 2:
City*:
State/Province*:
--
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Postal Code*:
Country*:
--
Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia, Plurinational State of
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte d'Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Macedonia, Republic of
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin (French Part)
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten (Dutch Part)
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
Tanzania, United Republic of
Thailand
Timor-leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
United States of America
Uruguay
Uzbekistan
Vanuatu
Venezuela, Bolivarian Republic of
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Business Phone:
Which best describes your job function?:
--
Clinical Research
Commercial Operations
Commercialization
Compliance
Consultant
Contract Services
Corporate Management
Drug Safety
Engineering
Environmental
Finance
HR
IT
Lab Management
Legal
Managed Care
Manufacturing/Processing
Market Research
Marketing
Media Planning
Medical Affairs
Medicare/Medicaid
Meeting Planner
Other
Packaging
Patient Programs/Services
Pharmacy
Procurement
Project Management
QA/QC
R&D
Regulatory Affairs
Reimbursement
Sales Management
Scientific
Supply Chain
Technology Transfer
Trade/Sales
Validation
X-Outcomes
Which best describes your business/industry?:
--
Academic
Audit & Financial Advisory
Biopharma
Bio Pharmaceutical
Biotech
Consultant
Contract Manufacturing Organization (CMO)
Contract Research Organization (CRO)
Convention/Visitors Bureau
Data Management/Technology Provider
Diagnostics
DMC (Destination Management Company)
Food
Government
Health Plan/Payer
Hospital/Medical Centers
Hotel
Laboratory
Legal/Law Firm
Marketing/Creative Agency
Medical Device
Non Profit
PBM (Pharmacy Benefit Management)
Pharmaceutical
Retail Pharmacy
Solutions Provider
Third Party Meeting Manager
Wholesaler/Distributer
checked
Yes, please subscribe me to BioPharm International's free e-newsletters.
By registering for this event, you agree to MJH Life Sciences ®
Terms and Conditions
,
Privacy Policy
, and understand your data will be used by MJH and its affiliates for amongst other things, alerting you to other services or products that you maybe interested in, and may be shared with or sold to third parties for their use, including possible contact with you through email or other communications, consistent with their respective privacy policy. If you do not agree to have your data used in this way, please contact
info@mjhassoc.com
.
*Denotes required.
Fit-to-Flex Design for Viral Vector Manufacturing
This event is now available on demand.
Event Overview:
Join us for an informative webcast with industry experts as they address critical challenges in viral vector manufacturing that Resilience's Marlborough, MA site was built to overcome. Situated in one of the fastest-growing life sciences hub and engineered to advance the field of viral vectors and gene therapy, this webinar will introduce the site’s innovative and efficient design. Don’t miss this opportunity to hear from key leaders in the viral vector and gene therapy manufacturing space.
Key Learning Objectives:
Gain insights into the versatile capabilities of the Marlborough Site and Resilience Gene Therapy Network, including multi-product support and flexible manufacturing suites, facilitating seamless transitions from clinical to commercial projects.
Explore new technologies and contamination control measures that drive efficiency and quality in viral vector manufacturing.
Understand the site’s end-to-end capabilities, spanning from cell bank to drug product fill, and how they streamline the supply chain for greater transparency and productivity.
Who Should Attend:
External manufacturing and strategic sourcing leaders, biopharmaceutical executives, manufacturing leaders, quality assurance professionals, and researchers in the field of advanced therapy manufacturing
Featured Speakers
John Kerwin, PhD
Technical Head of Gene Therapy Franchise
Resilience
John Kerwin, PhD
is the Technical Head of the Gene Therapy Franchise at Resilience. He is responsible for genome engineering, process and analytical development for viral vectors. He previously led Gene Therapy Manufacturing Sciences for Biogen where he was responsible for late-stage process development and validation of ocular and CNS-directed, AAV-based gene therapies. Prior, he built and directed a viral vector and therapeutic protein core facility at the University of Maryland and was a process development engineer at AERAS Global TB Vaccine Foundation developing viral vector-based and live vaccines. John holds a PhD in Chemical Engineering from the University of Maryland-College Park.
Malou Jacinto
Head of Quality-
Marlborough Resilience
Malou Jacinto
leads the Quality functions at the Resilience Marlborough facility. She has over 25 years of experience in biotech industry supporting Manufacturing and Quality Assurance. Malou has experience in new facility start-ups, facility debottlenecking-redesign and facility qualification. She spent over 20 years of her career at Genentech in Drug Product and Drug Substance Manufacturing and Quality Assurance for both Clinical and Commercial facilities. Malou obtained her Bachelor of Science in Chemistry from University of Santo Tomas, Manila, Philippines.
Shawn Fitzpatrick
Head of Manufacturing - Marlborough
Resilience
Shawn Fitzpatrick
, Head of Manufacturing at Resilience's Marlborough site, has over 25 years of experience in Biotechnology. His career spans prominent roles at TKT, Shire, Takeda, and Wuxi Biologics, specializing in facility start-ups and commercial launches. Beyond his industry expertise, he serves as a Board Member at the Just-a-Start Corporation, a non-profit championing equity through stable housing and biotechnology education programs.
Marion Glenn
Head of Technology - Marlborough
Resilience
Marion Glenn
is the Head of Technology for the Resilience Marlborough facility, encompassing the Manufacturing Sciences and Technology, Validation and Process Automation functions. Marion is a seasoned biotechnology engineer and leader with over 18 years of experience in the field. She started her career at Genentech, California, later acquired by the Roche Group. She received her Master of Sciences degree in biochemical engineering from the Engineer School of Marseille, FRANCE. Over her 15 years at Roche-Genentech Marion has made key contributions within Biologics process development, external and internal manufacturing process transfers across the world.
Tarran Pierfelice
Executive Director of Gene Therapy Commercial Development
Resilience
Tarran Pierfelice
is a stem cell biologist by training who is currently the Executive Director of Gene Therapy Commercial Development at Resilience. Dr. Pierfelice has more than a decade of gene therapy process development and manufacturing experience spanning business development and commercial operational roles both at CDMOs and cell and gene therapeutics companies. She was the Director of Business Development at Paragon Bioservices, where she was heavily involved in developing the company’s commercial strategy to drive organic growth to position the company for its sale to Catalent. After completing her MBA, Dr. Pierfelice worked at Editas Medicine leading its cell therapy pipeline and CMC strategy business development efforts. Dr. Pierfelice received a BS in Molecular Biology from Florida Institute of Technology, a PhD in Cellular and Molecular Medicine from Johns Hopkins University School of Medicine, and MBA from Harvard Business School.
For any technical questions please contact Nicole Valle:
NValle@mjhevents.com
FAQs and System Test
Outlook ❯
Google ❯